These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1740 related items for PubMed ID: 19467319

  • 1. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 2. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H, Peng Y, Lin Z, Zhang S, Guo Y.
    Microb Pathog; 2015 Sep; 83-84():35-40. PubMed ID: 25959527
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [Abstract] [Full Text] [Related]

  • 4. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R, Kayhty H, Wuorimaa T, Yaich M, Bailleux F, Zamir O, Eskola J.
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [Abstract] [Full Text] [Related]

  • 5. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.
    Clin Infect Dis; 2007 May 01; 44(9):1173-9. PubMed ID: 17407035
    [Abstract] [Full Text] [Related]

  • 6. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 7. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM, Lo Passo C, Scuderi A, Kolberg J, Baxendale H, Goldblatt D, Oggioni MR, Felici F, Andrew PW.
    Eur J Immunol; 2009 Jun 28; 39(6):1527-35. PubMed ID: 19499518
    [Abstract] [Full Text] [Related]

  • 8. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 9. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide.
    Csordas FC, Perciani CT, Darrieux M, Gonçalves VM, Cabrera-Crespo J, Takagi M, Sbrogio-Almeida ME, Leite LC, Tanizaki MM.
    Vaccine; 2008 Jun 02; 26(23):2925-9. PubMed ID: 18440673
    [Abstract] [Full Text] [Related]

  • 10. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
    Bermal N, Szenborn L, Chrobot A, Alberto E, Lommel P, Gatchalian S, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 02; 28(4 Suppl):S89-96. PubMed ID: 19325451
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 02; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [Abstract] [Full Text] [Related]

  • 12. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.
    J Infect Dis; 2001 Jan 15; 183(2):253-260. PubMed ID: 11110649
    [Abstract] [Full Text] [Related]

  • 13. Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-Lysine modified PspA.
    Santamaria R, Goulart C, Perciani CT, Barazzone GC, Carvalho R, Gonçalves VM, Leite LC, Tanizaki MM.
    Vaccine; 2011 Nov 03; 29(47):8689-95. PubMed ID: 21906649
    [Abstract] [Full Text] [Related]

  • 14. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA, Converso TR, Gonçalves VM, Leite LCC, Tanizaki MM, Barazzone GC.
    Clin Vaccine Immunol; 2017 Aug 03; 24(8):. PubMed ID: 28637805
    [Abstract] [Full Text] [Related]

  • 15. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

  • 16. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L, Jeurissen A, Mittler RS, Wuyts G, Michiels G, Boon L, Ceuppens JL, Bossuyt X.
    J Leukoc Biol; 2007 Sep 17; 82(3):638-44. PubMed ID: 17550973
    [Abstract] [Full Text] [Related]

  • 17. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H, ARIVAC Consortium.
    Vaccine; 2009 May 05; 27(20):2680-8. PubMed ID: 19428879
    [Abstract] [Full Text] [Related]

  • 18. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB, Carter AT, Hitchin E, Wells JM.
    J Infect Dis; 2007 Jan 15; 195(2):185-93. PubMed ID: 17191163
    [Abstract] [Full Text] [Related]

  • 19. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
    Ferreira DM, Arêas AP, Darrieux M, Leite LC, Miyaji EN.
    FEMS Immunol Med Microbiol; 2006 Mar 15; 46(2):291-7. PubMed ID: 16487311
    [Abstract] [Full Text] [Related]

  • 20. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A, Metzger DW.
    Vaccine; 2006 Jul 07; 24(27-28):5584-92. PubMed ID: 16730398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 87.